Compare Eli Lilly And Co (LLY) vs Western Union Co (WU) Price & Performance

Eli Lilly (LLY) trades at $1,176.69, down 1.01% on the day, amid a bullish technical outlook and strong fundamental performance. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 consensus. Revenue surged to $65.18B in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing growth prospects.

The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include elevated valuation multiples and competitive pressures in the pharmaceutical sector. With a consensus price target of $1,350, upside potential exists, but investors should weigh execution risks against the company's innovation pipeline.

Western Union (WU) trades at $6.145, up 0.57% on the day, with a mixed technical signal leaning bearish in moving averages but bullish overall. The company shows strong profitability with a 43.97% ROE and a net income margin of 9.79%, though revenue has declined from $4.5B in 2022 to $4.05B in 2025. Recent earnings have missed expectations in Q1 and Q2 2026, while the pending Intermex acquisition and a $200M cost-cutting plan aim to bolster future performance amid competitive pressures.

The stock presents a value opportunity with low P/E (5.1) and P/S (0.5) ratios, supported by a consensus price target of $6.86 offering ~12% upside. However, risks include earnings volatility, regulatory hurdles for the Intermex deal, and declining revenue trends. Analyst sentiment is cautious with only 12% buy ratings, suggesting a hold stance may be prudent until earnings stabilize and strategic initiatives show clearer results.